	Re: Twelve-month Results from the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-grade Non-muscle-invasive Bladder Cancer. Eur Urol Davis LE, Basourakos SP, Calaway AC. PMID: 42823220 [PubMed - as supplied by publisher]
	Re: Stockholm3 Versus Prostate-specific Antigen in Prostate Cancer Screening: 9 yr Outcomes Demonstrating Improved Detection of Aggressive Cancers and Reduced Overdiagnosis from the STHLM3 Trial. Eur Urol Gulati R, Etzioni R. PMID: 42823219 [PubMed - as supplied by publisher]
	Reply to Pierre-Etienne Gabriel and Evanguelos Xylinas's Letter to the Editor re: Ding Ding, Lei Qian, Di Jin, et al. Aptamer-based Positron Emission Tomography Imaging Allows Specific Detection of Residual Bladder Cancer: A First-in-Human Study. Eur Urol. 2026;89:93-5. Eur Urol Ding D, Wei W, Chen H, Tan W. PMID: 42823217 [PubMed - as supplied by publisher]
	Re: Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.01.008. Eur Urol , Uleri A, Radziszewski P, Pradere B. PMID: 42823216 [PubMed - as supplied by publisher]
	Real-world Outcomes of First-line Enfortumab Vedotin Plus Pembrolizumab in Elderly Patients With Advanced Urothelial Carcinoma. Anticancer Res Kaneko GO, Igarashi D, Morita M, Tsubota S, Baba Y, Shirotake S. PMID: 42823175 [PubMed - indexed for MEDLINE]
	Structured Symptom Monitoring During Enfortumab Vedotin Plus Pembrolizumab for Advanced or Metastatic Urothelial Carcinoma: Multicenter Retrospective Study. Anticancer Res Wakamiya T, Iwagami S, Enyo N, Shibano S, Nabeshima Y, Deguchi R, Kuwata K, Wada T, Yamashita S, Kohjimoto Y. PMID: 42823162 [PubMed - indexed for MEDLINE]
	Robot-assisted Radical Nephrectomy for Renal Cell Carcinoma With Versus Without Venous Tumor Thrombus. Anticancer Res Yoshino M, Yoshida K, Kobari Y, Fukuda H, Iizuka J, Takagi T. PMID: 42823156 [PubMed - indexed for MEDLINE]
	Primary malignant mesothelioma of the tunica vaginalis presenting as hydrocele: imaging pitfalls. BMJ Case Rep Naidu J, Joseph NG, Mohammed M, Baskaradoss VK. PMID: 42823143 [PubMed - indexed for MEDLINE]
	New and Novel Agents for Advanced Bladder Cancer. Urol Clin North Am Superdock M, Iyer G, Milowsky MI. PMID: 42823054 [PubMed - indexed for MEDLINE]
	The Role of Surgery in Locally Advanced and Oligometastatic Bladder Cancer. Urol Clin North Am Roessler N, von Deimling M, Miszczyk M, Vetterlein MW, Shariat SF. PMID: 42823053 [PubMed - indexed for MEDLINE]
	Trimodal Therapy for Muscle Invasive Bladder Cancer: An Update on Current Practices and Future Directions. Urol Clin North Am Dubic MG, Ward MC, Riggs S. PMID: 42823052 [PubMed - indexed for MEDLINE]
	The Role of Biomarkers in the Management of Muscle-Invasive Bladder Cancer. Urol Clin North Am Zhu A, Eraky A, Gabriel PE, Sfakianos JP. PMID: 42823051 [PubMed - indexed for MEDLINE]
	Adjuvant Therapy in Patients after Cystectomy. Urol Clin North Am Atiq SO, Miller EJ, Anker JF, Galsky MD. PMID: 42823050 [PubMed - indexed for MEDLINE]
	Sexual Function Preservation After Cystectomy. Urol Clin North Am McSweeney ST, Aydogdu C, Bole R, Bukavina L. PMID: 42823048 [PubMed - indexed for MEDLINE]
	What Is the Proper Extent of Lymph Node Dissection During a Radical Cystectomy for Bladder Cancer? Urol Clin North Am Ghasemzadeh A, Bochner BH. PMID: 42823047 [PubMed - indexed for MEDLINE]
	Open and Robotic Radical Cystectomy for Muscle-Invasive Bladder Cancer: Techniques, Outcomes, and Evidence. Urol Clin North Am Sadiq S, Nativ O, Ritch CR. PMID: 42823046 [PubMed - indexed for MEDLINE]
	Advancements in Bladder-Sparing Strategies for Muscle-Invasive Bladder Cancer: A Comprehensive Review. Urol Clin North Am Chung R, Zibelman MR, Wong JK, Kutikov A. PMID: 42823045 [PubMed - indexed for MEDLINE]
	Prehabilitation and Patient Optimization for Cystectomy. Urol Clin North Am Britton CJ, Galloway LAS, Luckenbaugh AN. PMID: 42823044 [PubMed - indexed for MEDLINE]
	Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer: Current Evidence, Evolving Strategies, and Future Directions. Urol Clin North Am Eber J, Matulay JT. PMID: 42823043 [PubMed - indexed for MEDLINE]
	A Phase I Clinical Trial of Chemoimmunotherapy with Alternating Intravesical Gemcitabine and Bacillus Calmette-Guérin (GemBCG) for BCG-Exposed High-Grade Non-Muscle-Invasive Bladder Cancer. J Urol Gaffney CD, Alam SM, Wald G, Sjoberg D, Eichholz J, Sarungbam J, D'Souza N, Lavery J, Hernandez C, Tomerlein M, Zagajeski P, Hildreth KW, Donat S, Smith R, Donahue T, Goh A, Bochner B, Al-Ahmadie H, Pietzak E. PMID: 42821609 [PubMed - as supplied by publisher]

Articles 1 - 20 / 181885

Page 1 of 9095



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy